ANEBULO PHARMACEUTICALS INC (ANEB)

US0345691036 - Common Stock

2.2999  +0.09 (+4.07%)

News Image
4 days ago - InvestorPlace

ANEB Stock Earnings: Anebulo Pharmaceuticals Beats EPS for Q3 2024

ANEB stock results show that Anebulo Pharmaceuticals beat analyst estimates for earnings per share the third quarter of 2024.

News Image
4 days ago - BusinessInsider

ANEB Stock Earnings: Anebulo Pharmaceuticals Beats EPS for Q3 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Anebulo Pharmaceuticals (NASDAQ:ANEB) just reported results for the third quart...

News Image
8 months ago - Anebulo Pharmaceuticals, Inc.

Anebulo Pharmaceuticals Announces New CEO

News Image
a year ago - Anebulo Pharmaceuticals, Inc.

Anebulo Pharmaceuticals Reports Third Quarter Fiscal 2023 Financial Results and Recent Updates

/PRNewswire/ -- Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from...

News Image
a year ago - Anebulo Pharmaceuticals, Inc.

Anebulo Pharmaceuticals Announces Positive Complete Phase 2 Clinical Data Demonstrating Potential of ANEB-001 as a Treatment for Acute Cannabinoid Intoxication

/PRNewswire/ -- Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB) (the "Company" or "Anebulo"), a clinical-stage biopharmaceutical company developing novel...